(Total Views: 577)
Posted On: 05/26/2024 11:50:04 AM
Post# of 148870
Re: ScottyDoggs #143701
There is no way a pharmaceutical company would spend money on a drug like leronlimab and then shelve it.
1) companies don't buy access to products like this without figuring their possible return on investment.
2) Too many physicians already know about Leronlimab and would raise a ruckus if it were to disappear somehow.
3) Please worry about something else you can't control like sunspots or politics or earthquakes.
1) companies don't buy access to products like this without figuring their possible return on investment.
2) Too many physicians already know about Leronlimab and would raise a ruckus if it were to disappear somehow.
3) Please worry about something else you can't control like sunspots or politics or earthquakes.
(6)
(0)
Scroll down for more posts ▼